ADDvise Group to arrange fixed income investor calls - Regulatory information

18-11-2020   Regulatory press release

ADDvise Group AB (publ) (“ADDvise” or the “Company”) has mandated Pareto Securities AB to arrange fixed income investor calls commencing on 20 November 2020.

Subject to, inter alia, market conditions, a SEK-denominated senior secured bond issue in an initial amount of MSEK 250 with a tenor of 3 years may follow. The net proceeds from the contemplated bond issue will be utilised to refinance the Company’s outstanding bonds and other debt facilities, finance the previously announced acquisition of MRC Systems Ltd, and for general corporate purposes.

In conjunction with the contemplated bond issue and the acquisition of MRC Systems Ltd., Rikard Akhtarzand (CEO, board member and shareholder), Staffan Torstensson (chairman of the board and shareholder), Per Åhlgren (shareholder) and Magnus Vahlquist (shareholder) have expressed their intention to during the period 25 January to 8 February 2021 exercise their right to subscribe for shares under the Company’s warrant programme, which will result in aggregate gross proceeds to the Company of approximately MSEK 14 before transaction costs.


For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 18 November 2020 at 07:45 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North Growth Market and Mangold Fondkommission AB, +46 8 503 015 50,, is the Company's Certified Adviser. Additional information is available at

Latest press releases

ADDvise announces preliminary result for 2022 which is stronger than expected


The preliminary result for ADDvise Group for the full year 2022 significantly deviates from what ADDvise Group considers to be current market expectations. [image] The net sales pro forma full year 2022 rolling 12 months amounted to SEK 1,097 million with an adjusted EBITDA pro forma of SEK 241 million. The financial targets for the…

ADDvise receives order worth USD 3.5 million


ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment and medical supplies to hospitals, clinics, medical offices and medical equipment suppliers. The order is worth approximately USD 3.5 million. The order consists of delivery of the prescription dietary supplemental Folite, developed and manufactured by…

ADDvise receives order worth USD 1.8 million


ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Nasser Saeed Al Hajri & Partners Contracting (NHS & Partners), a leading construction contractor in the United Arab Emirates. The order is worth approximately USD 1.8 million. The order involves the detailed design, supply and installation of an ISO 8 and ISO 7…